The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.

Benzer Materyaller

• Ecstasy cannot be assumed to be 3,4-methylenedioxyamphetamine (MDMA)
  Yazar:: Green, AR, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy') to rats
  Yazar:: Mechan, Annis O, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or ‘ecstasy') administration
  Yazar:: Colado, M I, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy') on dopamine neurones in mouse brain
  Yazar:: Colado, M Isabel, ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
  Yazar:: O'Hearn, E, ve diğerleri
  Baskı/Yayın Bilgisi: (1988)